CR9954A - Derivados de pirazina - Google Patents

Derivados de pirazina

Info

Publication number
CR9954A
CR9954A CR9954A CR9954A CR9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A CR 9954 A CR9954 A CR 9954A
Authority
CR
Costa Rica
Prior art keywords
compounds
pirazine
derivatives
preparation
pirazine derivatives
Prior art date
Application number
CR9954A
Other languages
English (en)
Inventor
Richard Gibson Kart
Poinsard Cedric
Susanne Glossop Melanie
Martin Denton Stephen
Ian Kemp Mark
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of CR9954A publication Critical patent/CR9954A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion se refiere a compuestos de formula y a sales y solvatos farmaceuticamente aceptables de los mismos, a procedimientos para su preparacion, a intermedios utiles en su preparacion y a composiciones que contienen dichos compuestos, y a los usos de dichos compuestos para el tratamiento de dolor.
CR9954A 2005-11-04 2008-05-07 Derivados de pirazina CR9954A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04

Publications (1)

Publication Number Publication Date
CR9954A true CR9954A (es) 2008-05-28

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9954A CR9954A (es) 2005-11-04 2008-05-07 Derivados de pirazina

Country Status (27)

Country Link
US (1) US7572797B2 (es)
EP (1) EP1945630B1 (es)
JP (1) JP2009514937A (es)
KR (1) KR20080066073A (es)
CN (1) CN101356169A (es)
AP (1) AP2008004468A0 (es)
AR (1) AR057855A1 (es)
AT (1) ATE525372T1 (es)
AU (1) AU2006310215A1 (es)
BR (1) BRPI0618129A2 (es)
CA (1) CA2624621C (es)
CR (1) CR9954A (es)
DO (1) DOP2006000243A (es)
EA (1) EA200801011A1 (es)
EC (1) ECSP088412A (es)
ES (1) ES2371932T3 (es)
GT (1) GT200600475A (es)
IL (1) IL191059A0 (es)
MA (1) MA29926B1 (es)
NL (1) NL2000284C2 (es)
NO (1) NO20082496L (es)
PE (1) PE20070715A1 (es)
TN (1) TNSN08196A1 (es)
TW (1) TW200804353A (es)
UY (1) UY29893A1 (es)
WO (1) WO2007052123A2 (es)
ZA (1) ZA200803671B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
EP1741708A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
CA2684105C (en) 2007-05-03 2011-09-06 Pfizer Limited Pyridine derivatives
WO2008135830A1 (en) * 2007-05-03 2008-11-13 Pfizer Limited N- [6-amino-s- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
US8614255B2 (en) * 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
CL2008003651A1 (es) 2007-12-10 2009-06-19 Novartis Ag Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
KR20100124262A (ko) 2008-02-13 2010-11-26 에자이 알앤드디 매니지먼트 가부시키가이샤 비시클로아민 유도체
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
MX360323B (es) 2012-04-25 2018-10-29 Raqualia Pharma Inc Derivados de pirrolopiridinona como bloqueadores de ttx-s.
US9079866B2 (en) 2013-02-04 2015-07-14 Janssen Pharmaceutica Nv Flap modulators
TWI644899B (zh) 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
JP2017526706A (ja) * 2014-09-10 2017-09-14 エピザイム，インコーポレイティド イソオキサゾールカルボキサミド化合物
EP3778595B1 (en) 2015-02-27 2021-08-25 Calcimedica, Inc. Pancreatitis treatment
CA2995094A1 (en) 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
JP2023528537A (ja) 2020-03-20 2023-07-04 カルシメディカ，インク． 急性肺傷害及び急性呼吸窮迫症候群を処置するための方法及び組成物
CA3198798A1 (en) 2020-11-13 2022-05-19 Kenneth Stauderman Improved synthesis of crac channel inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
BR0214309A (pt) * 2001-11-21 2004-10-13 Upjohn Co Derivados aril-1,4-pirazina substituìdos
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
WO2006047504A1 (en) * 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Aromatic amides as inhibitors of c-fms kinase

Also Published As

Publication number Publication date
AU2006310215A1 (en) 2007-05-10
WO2007052123A2 (en) 2007-05-10
GT200600475A (es) 2007-07-06
WO2007052123A3 (en) 2007-07-12
US7572797B2 (en) 2009-08-11
AP2008004468A0 (en) 2008-06-30
JP2009514937A (ja) 2009-04-09
BRPI0618129A2 (pt) 2011-08-16
EP1945630B1 (en) 2011-09-21
NO20082496L (no) 2008-07-24
TW200804353A (en) 2008-01-16
PE20070715A1 (es) 2007-08-11
KR20080066073A (ko) 2008-07-15
UY29893A1 (es) 2007-06-29
ATE525372T1 (de) 2011-10-15
ES2371932T3 (es) 2012-01-11
CA2624621A1 (en) 2007-05-10
CA2624621C (en) 2010-11-30
TNSN08196A1 (fr) 2009-10-30
DOP2006000243A (es) 2007-05-31
ECSP088412A (es) 2008-05-30
AR057855A1 (es) 2007-12-19
IL191059A0 (en) 2008-12-29
EP1945630A2 (en) 2008-07-23
ZA200803671B (en) 2009-03-25
NL2000284A1 (nl) 2007-05-07
MA29926B1 (fr) 2008-11-03
CN101356169A (zh) 2009-01-28
US20070105872A1 (en) 2007-05-10
EA200801011A1 (ru) 2009-02-27
NL2000284C2 (nl) 2007-09-28

Similar Documents

Publication Publication Date Title
CR9954A (es) Derivados de pirazina
CR8859A (es) Derivados de piridina
DOP2009000254A (es) Derivados de piridina
CU20110145A7 (es) Derivados de sulfonamida
AR055076A1 (es) Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica.
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
UY31471A1 (es) Derivados bis-(sulfonilamino) en terapia 066
CR11106A (es) Inhibidores de cinasa p710 s6
UY31046A1 (es) Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
UY30460A1 (es) Compuestos terapéuticos
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
HN2008001666A (es) Derivados acidos de cicloalquilamino
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
CR10376A (es) Derivados de terfenil para el tratamiento de la enfermedad de alzheimer
HN2003000379A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
PA8589801A1 (es) Aminoalcoxiindoles
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
GT200400143A (es) Compuestos
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones
PA8653801A1 (es) Derivados de octahidropirrolo [3,4-c] pirrol
UY29817A1 (es) Nuevos compuestos de azetidina, composiciones farmacéuticas que los contienen, procesos de preparación y uso terapéutico de los mismos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)